← The Wire
ACETNasdaq
Adicet Bio, Inc.
Pharmaceutical Preparations · DE · CIK 1720580
Adicet Bio develops off-the-shelf gamma delta T cell therapies for autoimmune diseases and cancer
$75M
Market cap
$8.56
Last close
+2.3%
1D
+4.0%
5D
74K
Volume
Price · last 39 sessions+1.3%
May 4L $7.22 · H $9.31Jun 29
249
Total filings
Jun 18, 2026
Last filing
12/26
Fiscal year end
8-KShareholder VoteJun 18, 202610-K/A10-K/AMay 20, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 20268-KEquity IssuanceApr 28, 2026SC 13D/ASC 13D/AApr 10, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KReg FD Disclosure · Company UpdateJan 7, 20268-KBylaw Amendment · Company UpdateDec 29, 20258-KShareholder VoteDec 19, 2025DEF 14ADEF 14ANov 17, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KDelisting NoticeOct 7, 20258-KMaterial AgreementOct 7, 2025424B5424B5Oct 7, 20258-KCompany UpdateOct 7, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KExit / Disposal Costs · Company UpdateJul 23, 20258-KShareholder VoteJun 13, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive Change · Reg FD DisclosureApr 17, 20258-KDelisting NoticeApr 11, 2025424B5424B5Mar 18, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 20258-KCompany UpdateFeb 5, 20258-KReg FD Disclosure · Company UpdateDec 19, 20248-KAgreement TerminatedNov 27, 20248-KReg FD Disclosure · Company UpdateNov 18, 20248-KMaterial AgreementNov 15, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KReg FD Disclosure · Company UpdateOct 16, 20248-KReg FD Disclosure · Company UpdateSep 30, 20248-KReg FD Disclosure · Company UpdateSep 19, 20248-KCompany UpdateSep 10, 20248-KExecutive Change · Reg FD DisclosureAug 19, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KReg FD DisclosureJul 8, 20248-KReg FD Disclosure · Company UpdateJun 24, 20248-KExecutive Change · Bylaw AmendmentJun 7, 20248-KReg FD DisclosureJun 5, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 20248-KReg FD DisclosureMay 10, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 20248-KReg FD Disclosure · Company UpdateApr 22, 20248-KMaterial AgreementMar 22, 2024424B5424B5Mar 22, 202410-K10-KMar 19, 20248-KResults of OperationsMar 19, 2024SC 13GSC 13GFeb 27, 2024SC 13GMS INITIALFeb 12, 2024SC 13GSC 13GFeb 5, 20248-KMaterial Agreement · Results of OperationsJan 24, 2024424B5424B5Jan 24, 2024424B5424B5Jan 22, 2024SC 13GSC 13GJan 19, 20248-KReg FD DisclosureJan 16, 20248-KReg FD Disclosure · Company UpdateJan 4, 20248-KExecutive ChangeNov 13, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KExecutive Change · Reg FD DisclosureJul 11, 20238-KReg FD Disclosure · Company UpdateJun 26, 20238-KMaterial AgreementJun 5, 20238-KExecutive Change · Shareholder VoteJun 5, 20238-KReg FD Disclosure · Company UpdateMay 18, 2023
Insider Activity
In the 90 days to Oct 8, 2025: 1 insider bought $5.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2025 | Orbimed Advisors LlcTenPercentOwner | Buy | 3,500,000 | $1.00 | $3.5M |
| Oct 8, 2025 | Orbimed Advisors LlcTenPercentOwner | Buy | 1,500,000 | $1.00 | $1.5M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance